EUVIMEDEUVIMED entdecken
Open Access

A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4

Yuanyuan Yong, Lu Yan, Jing Wei, Chi Feng, Lu Yu, Jianming Wu, Minsong Guo, Dongsheng Fan, Chonglin Yu, Dalian Qin, Xiaogang Zhou, Anguo Wu

Theranostics · 2024 · 14 (16) · 6161-6184

DOI: 10.7150/thno.98172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Yuanyuan Yong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluat…. Hauptthemen laut MEDLINE: Ferroptosis, Alzheimer Disease, Phospholipid Hydroperoxide Glutathione Peroxidase, Caenorhabditis elegans. Die Arbeit wurde bisher 117-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAlzheimer DiseasePhospholipid Hydroperoxide Glutathione PeroxidaseCaenorhabditis elegansReactive Oxygen SpeciesNF-E2-Related Factor 2AnimalsPC12 CellsRatsDisease Models, AnimalHumansIronSignal TransductionNeuronsCarbolines

Stichwörter der Autor:innen

AMPK/Nrf2/GPX4Alzheimer's diseaseFerroptosisGPX4 activationthonningianin A

Substanzen

Phospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesNF-E2-Related Factor 2Ironglutathione peroxidase 4, ratRSL3 compoundCarbolines

Autor:innen und Institutionen

  • Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysi…
  • School of Ophthalmology, Chengdu University of Traditional Chinese Medicine, Chengdu, China, 610075.
  • Department of Pharmacy, First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Gui Yang, China, 550000.
  • Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China, 646000.

Zitieren

APA

Yong, Y., Yan, L., Wei, J., Feng, C., Yu, L., Wu, J., Guo, M., Fan, D., Yu, C., Qin, D., Zhou, X., & Wu, A. (2024). A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4. Theranostics, 14(16), 6161-6184. https://doi.org/10.7150/thno.98172

Vancouver

Yong Y, Yan L, Wei J, Feng C, Yu L, Wu J, et al. A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4. Theranostics. 2024;14(16):6161-6184. doi:10.7150/thno.98172

BibTeX
@article{Yong2024,
  author = {Yong, Yuanyuan and Yan, Lu and Wei, Jing and Feng, Chi and Yu, Lu and Wu, Jianming and Guo, Minsong and Fan, Dongsheng and Yu, Chonglin and Qin, Dalian and Zhou, Xiaogang and Wu, Anguo},
  title = {A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {16},
  pages = {6161--6184},
  doi = {10.7150/thno.98172}
}
Kostenlos starten →